PMV Pharmaceuticals, Inc. - stock earnings
PMVP Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -15.8 million USD | 1.6 million USD |
2023Q3 | -16.6 million USD | ? USD |
2023Q2 | -17.4 million USD | ? USD |
2023Q1 | -16.8 million USD | ? USD |
2022Q4 | -19.3 million USD | ? USD |
2022Q3 | -18.2 million USD | ? USD |
2022Q2 | -17.3 million USD | ? USD |
2022Q1 | -18.4 million USD | ? USD |
2021Q4 | -18.4 million USD | ? USD |
2021Q3 | -15.0 million USD | ? USD |
2021Q2 | -12.9 million USD | ? USD |
2021Q1 | -11.6 million USD | ? USD |
2020Q4 | -10.5 million USD | ? USD |
2020Q3 | -8.8 million USD | ? USD |
2020Q2 | -8.0 million USD | ? USD |
2020Q1 | -7.3 million USD | ? USD |
2019Q4 | -7.0 million USD | ? USD |
2019Q3 | -6.2 million USD | ? USD |
PMVP Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -69.0 million USD | ? USD |
2022 | -73.3 million USD | ? USD |
2021 | -57.8 million USD | ? USD |
2020 | -34.4 million USD | ? USD |
2019 | -25.4 million USD | ? USD |
2018 | -17.5 million USD | ? USD |
PMVP
Price: $1.87
52 week price:
Earnings Per Share: -1.44 USD
P/E Ratio: -1.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 230900
Market Capitalization: 82.3 million